Ritu Shrestha

1.6k total citations
36 papers, 1.3k citations indexed

About

Ritu Shrestha is a scholar working on Molecular Biology, Oncology and Infectious Diseases. According to data from OpenAlex, Ritu Shrestha has authored 36 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Oncology and 7 papers in Infectious Diseases. Recurrent topics in Ritu Shrestha's work include RNA Interference and Gene Delivery (8 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Clostridium difficile and Clostridium perfringens research (7 papers). Ritu Shrestha is often cited by papers focused on RNA Interference and Gene Delivery (8 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Clostridium difficile and Clostridium perfringens research (7 papers). Ritu Shrestha collaborates with scholars based in United States, Australia and Egypt. Ritu Shrestha's co-authors include Joseph A. Sorg, Karen L. Wooley, Michael Francis, Aparna Jayachandran, Sandani Samarajeewa, Dorothy H. Crawford, Kim R. Bridle, Jason C. Steel, Mahmoud Elsabahy and Bijay Dhungel and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Nano Letters.

In The Last Decade

Ritu Shrestha

36 papers receiving 1.3k citations

Peers

Ritu Shrestha

BIOMA

ONCOL

Peiyu Li China

Naoya Kitamura Japan

Neeraj Chauhan United States

Diane M. Maher United States

Clifford Longley United States

Arindam Mondal United States

Tao Hu China

Eva M. Gálvez Spain

G. Lopez‐Berestein United States

Peiyu Li China

Ritu Shrestha

445 ×0.8

228 ×0.6

218 ×0.9

BIOMA

89 ×0.4

ONCOL

316 ×1.8

Citations per year, relative to Ritu Shrestha Ritu Shrestha (= 1×) peers Peiyu Li

Countries citing papers authored by Ritu Shrestha

Since Specialization

Citations

This map shows the geographic impact of Ritu Shrestha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ritu Shrestha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ritu Shrestha more than expected).

Fields of papers citing papers by Ritu Shrestha

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ritu Shrestha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ritu Shrestha. The network helps show where Ritu Shrestha may publish in the future.

Co-authorship network of co-authors of Ritu Shrestha

This figure shows the co-authorship network connecting the top 25 collaborators of Ritu Shrestha. A scholar is included among the top collaborators of Ritu Shrestha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ritu Shrestha. Ritu Shrestha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shrestha, Ritu, Kim R. Bridle, Dorothy H. Crawford, & Aparna Jayachandran. (2021). Immune checkpoint molecules are regulated by transforming growth factor (TGF)-β1-induced epithelial-to-mesenchymal transition in hepatocellular carcinoma. International Journal of Medical Sciences. 18(12). 2466–2479. 20 indexed citations

Cao, Lu, Prashanth Prithviraj, Ritu Shrestha, et al.. (2021). Prognostic Role of Immune Checkpoint Regulators in Cholangiocarcinoma: A Pilot Study. Journal of Clinical Medicine. 10(10). 2191–2191. 15 indexed citations

Shrestha, Ritu, et al.. (2019). The requirement for co-germinants during Clostridium difficile spore germination is influenced by mutations in yabG and cspA. PLoS Pathogens. 15(4). e1007681–e1007681. 38 indexed citations

Shrestha, Ritu & Joseph A. Sorg. (2019). Terbium chloride influences Clostridium difficile spore germination. Anaerobe. 58. 80–88. 12 indexed citations

Dhungel, Bijay, et al.. (2018). Evaluation of the Glypican 3 promoter for transcriptional targeting of hepatocellular carcinoma. Gene Therapy. 25(2). 115–128. 14 indexed citations

Shrestha, Ritu, Prashanth Prithviraj, Matthew Anaka, et al.. (2018). Monitoring Immune Checkpoint Regulators as Predictive Biomarkers in Hepatocellular Carcinoma. Frontiers in Oncology. 8. 269–269. 103 indexed citations

Dhungel, Bijay, Ritu Shrestha, Kim R. Bridle, et al.. (2018). Spotlight on Bortezomib: potential in the treatment of hepatocellular carcinoma. Expert Opinion on Investigational Drugs. 28(1). 7–18. 27 indexed citations

Shrestha, Ritu, Steve W. Lockless, & Joseph A. Sorg. (2017). A Clostridium difficile alanine racemase affects spore germination and accommodates serine as a substrate. Journal of Biological Chemistry. 292(25). 10735–10742. 33 indexed citations

Shrestha, Ritu & Joseph A. Sorg. (2017). Hierarchical recognition of amino acid co-germinants during Clostridioides difficile spore germination. Anaerobe. 49. 41–47. 44 indexed citations

10.

Pokharel, Sunil, Buddha Basnyat, Amit Arjyal, et al.. (2017). Co-trimoxazole versus azithromycin for the treatment of undifferentiated febrile illness in Nepal: study protocol for a randomized controlled trial. Trials. 18(1). 450–450. 6 indexed citations

11.

Jayachandran, Aparna, et al.. (2017). Murine hepatocellular carcinoma derived stem cells reveal epithelial-to-mesenchymal plasticity. World Journal of Stem Cells. 9(9). 159–168. 12 indexed citations

12.

Jayachandran, Aparna, et al.. (2017). Epithelial-to-Mesenchymal Transition: A Mediator of Sorafenib Resistance in Advanced Hepatocellular Carcinoma. Current Cancer Drug Targets. 17(8). 698–706. 67 indexed citations

13.

Black, Kvar C. L., Aida Ibricevic, Sean P. Gunsten, et al.. (2016). In vivo fate tracking of degradable nanoparticles for lung gene transfer using PET and Ĉerenkov imaging. Biomaterials. 98. 53–63. 31 indexed citations

14.

Shen, Yuefei, Ritu Shrestha, Aida Ibricevic, et al.. (2013). Antisense peptide nucleic acid-functionalized cationic nanocomplex for in vivo mRNA detection. Interface Focus. 3(3). 20120059–20120059. 16 indexed citations

15.

Ibricevic, Aida, Ke Zhang, Ritu Shrestha, et al.. (2013). PEGylation of cationic, shell-crosslinked-knedel-like nanoparticles modulates inflammation and enhances cellular uptake in the lung. Nanomedicine Nanotechnology Biology and Medicine. 9(7). 912–922. 33 indexed citations

16.

Francis, Michael, et al.. (2013). Bile Acid Recognition by the Clostridium difficile Germinant Receptor, CspC, Is Important for Establishing Infection. PLoS Pathogens. 9(5). e1003356–e1003356. 214 indexed citations

17.

Shrestha, Ritu, Mahmoud Elsabahy, Stephanie Florez-Pollack, Sandani Samarajeewa, & Karen L. Wooley. (2012). Endosomal escape and siRNA delivery with cationic shell crosslinked knedel-like nanoparticles with tunable buffering capacities. Biomaterials. 33(33). 8557–8568. 65 indexed citations

18.

Zou, Jiong, et al.. (2012). pH-Triggered reversible morphological inversion of orthogonally-addressable poly(3-acrylamidophenylboronic acid)-block-poly(acrylamidoethylamine) micelles and their shell crosslinked nanoparticles. Polymer Chemistry. 3(11). 3146–3146. 33 indexed citations

19.

Shrestha, Ritu, Mahmoud Elsabahy, Hannah Luehmann, et al.. (2012). Hierarchically Assembled Theranostic Nanostructures for siRNA Delivery and Imaging Applications. Journal of the American Chemical Society. 134(42). 17362–17365. 41 indexed citations

20.

Shrestha, Ritu, et al.. (2011). Porphyrin-crosslinked block copolymer assemblies as photophysically-active nanoscopic devices. Journal of Materials Chemistry. 21(25). 8983–8983. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact